Login
$CASIF
$0.15 +$0.00 (0.0%) Close

Ownership

13F as of Q2 2026 · 20.6M shares outstanding

Who owns CASIF?

By type of holder
Institutions 0.0% Insiders 0.0% Everyone else 100.0%
Concentration Top 10 holders own 212.0%
WEI-WU HE, Ph.D. 116.7% · James Huang 22.6%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
1
0 vs last qtr
Net shares bought
−128
by institutions in Q2 2026
New / sold out
1 / 1
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • West Paces Advisors Inc. NEW +100
Biggest sellers in Q2 2026
  • Simplex Trading, LLC SOLD OUT −228

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for CASI Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+67.8%
+10.91% a year
Each share's claim on the business
−40.4%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$3.55M vs $34.1M
over 6 fiscal years
Diluted shares, split-adjusted
10.7M14.7M18.7M2020: 11.0M shares'202021: 13.6M shares'212022: 13.6M shares'222023: 13.4M shares'232024: 15.3M shares'242025: 18.5M shares'25
Buybacks Stock-based comp
$0$3.9M$7.8M2020 buybacks: $02020 stock comp: $7.8M'202021 buybacks: $02021 stock comp: $7.8M'212022 buybacks: $3.3M2022 stock comp: $7.0M'222023 buybacks: $278.0K2023 stock comp: $7.2M'232024 buybacks: $02024 stock comp: $1.3M'242025 buybacks: $02025 stock comp: $3.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%
Quarterly turnover
71.9%
of institutional shares changed hands
Top 10 managers, median time held
0 quarters

Super Investors

Investment managers reporting CASIF on Form 13F
ST
Simplex Trading, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
WP
West Paces Advisors Inc.
Shares
100
% of company
0.00%
Change vs last qtr
NEW
Held since
Q2 '26

Institutional Funds

Mutual funds and ETFs reporting CASIF on Form N-PORT; together they hold 0.2% of the company
VT
Position value
$82.9K
% of company
0.16%
% of the fund
0.00%
As of
September 30, 2023
AD
Allianz Variable Insurance Products Trust
Position value
$513
% of company
0.00%
% of the fund
0.00%
As of
March 31, 2024

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
WH
WEI-WU HE, Ph.D.
5%+ holder13D · 58.8%
Shares
24.0M
% of company
116.68%
Change vs last qtr
—
Held since
—
JH
James Huang
5%+ holder13D · 22.5%
Shares
4.7M
% of company
22.63%
Change vs last qtr
—
Held since
—

11 more holders behind a free account

See every insider and 5%+ holder of CASI Pharmaceuticals Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support